Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Effect of Nigella sativa Intake on Oxidative Stress and Inflammation in Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Author(s): Hossein Hosseini, Farideh Ghavidel, Mahdieh Aliyari, Seyed Isaac Hashemy, Tannaz Jamialahmadi and Amirhossein Sahebkar*

Volume 25, Issue 7, 2024

Published on: 04 October, 2023

Page: [896 - 907] Pages: 12

DOI: 10.2174/0113892010266109230928000134

Price: $65

Abstract

Background: Several studies have shown that the intake of N. sativa has a beneficial effect on metabolic syndrome and related disorders. In this meta-analysis, our primary objective was to assess the impact of Nigella sativa consumption on inflammation and oxidative stress biomarkers among individuals diagnosed with metabolic syndrome and its associated conditions.

Methods: Our search was conducted on prominent online databases such as Web of Science, Scopus, PubMed, and EMBASE, utilizing relevant keywords until August 2023.

Results: This meta-analysis was performed on 16 RCTs comprising 1033 participants. Our results showed that intake of Nigella sativa significantly decreased CRP (SMD: -0.60; (95% CI: from -0.96 to -0.23); P = 0.00), TNF-α (SMD: -0.53; (95% CI: from -0.74 to -0.53); P = 0.00); IL-6 (SMD: -0.54 ; (95% CI: from -1.01 to -0.07); P = 0.02), and MDA: (SMD: -1.28; (95% CI: from -2.11 to -0.46); P = 0.00) levels. In addition, SOD: (SMD: 1.35; (95% CI, from 0.77 to 1.93); P = 0.00) and TAC (SMD: 2.82; (95% CI, from 0.55 to 5.084); P = 0.01) levels significantly increased in the intervention group compared to the placebo group.

Conclusion: Our results showed that THE consumption of N. sativa could be associated with improved oxidative stress and inflammation in patients with metabolic syndrome and related disorders.

« Previous Next »
Graphical Abstract

[1]
Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 2004, 114(12), 1752-1761.
[http://dx.doi.org/10.1172/JCI21625] [PMID: 15599400]
[2]
Akbari, M.; Ostadmohammadi, V.; Tabrizi, R.; Mobini, M.; Lankarani, K.B.; Moosazadeh, M.; Heydari, S.T.; Chamani, M.; Kolahdooz, F.; Asemi, Z. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and metaanalysis of randomized controlled trials. Nutr. Metab., 2018, 15(1), 39.
[http://dx.doi.org/10.1186/s12986-018-0274-y] [PMID: 29930690]
[3]
Rives, C.; Fougerat, A.; Ellero-Simatos, S.; Loiseau, N.; Guillou, H.; Gamet-Payrastre, L.; Wahli, W. Oxidative stress in NAFLD: Role of nutrients and food contaminants. Biomolecules, 2020, 10(12), 1702.
[http://dx.doi.org/10.3390/biom10121702] [PMID: 33371482]
[4]
Dobrowolski, P.; Prejbisz, A.; Kuryłowicz, A.; Baska, A.; Burchardt, P.; Chlebus, K.; Dzida, G.; Jankowski, P.; Jaroszewicz, J.; Jaworski, P.; Kamiński, K.; Kapłon-Cieślicka, A.; Klocek, M.; Kukla, M.; Mamcarz, A.; Mastalerz-Migas, A.; Narkiewicz, K.; Ostrowska, L.; Śliż, D.; Tarnowski, W.; Wolf, J.; Wyleżoł, M.; Zdrojewski, T.; Banach, M.; Januszewicz, A.; Bogdański, P. Metabolic syndrome a new definition and management guidelines. Arch. Med. Sci., 2022, 18(5), 1133-1156.
[http://dx.doi.org/10.5114/aoms/152921] [PMID: 36160355]
[5]
Gholamnezhad, Z.; Havakhah, S.; Boskabady, M.H. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review. J. Ethnopharmacol., 2016, 190, 372-386.
[http://dx.doi.org/10.1016/j.jep.2016.06.061] [PMID: 27364039]
[6]
Hadi, V.; Kheirouri, S.; Alizadeh, M.; Khabbazi, A.; Hosseini, H. Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial. Avicenna J. Phytomed., 2016, 6(1), 34-43.
[PMID: 27247920]
[7]
Du Clos, T.W. Function of C-reactive protein. Ann. Med., 2000, 32(4), 274-278.
[http://dx.doi.org/10.3109/07853890009011772] [PMID: 10852144]
[8]
Zhang, D.; Sun, M.; Samols, D.; Kushner, I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem., 1996, 271(16), 9503-9509.
[http://dx.doi.org/10.1074/jbc.271.16.9503] [PMID: 8621622]
[9]
Haffner, S.M. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol., 2006, 97(2), 3-11.
[http://dx.doi.org/10.1016/j.amjcard.2005.11.010] [PMID: 16442931]
[10]
Mahdavi, R.; Namazi, N.; Alizadeh, M.; Farajnia, S. Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: A randomized double-blind, placebo-controlled clinical trial. J. Clin. Lipidol., 2016, 10(5), 1203-1211.
[http://dx.doi.org/10.1016/j.jacl.2015.11.019] [PMID: 27678438]
[11]
Roshan, H.; Nikpayam, O.; Sedaghat, M.; Sohrab, G. Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: A randomised clinical trial. Br. J. Nutr., 2018, 119(3), 250-258.
[http://dx.doi.org/10.1017/S0007114517003439] [PMID: 29307310]
[12]
Bagherniya, M.; Johnston, T.P.; Sahebkar, A. Regulation of apolipoprotein b by natural products and nutraceuti-cals: A comprehensive review. Curr. Med. Chem., 2021, 28(7), 1363-1406.
[http://dx.doi.org/10.2174/0929867327666200427092114] [PMID: 32338202]
[13]
Bagherniya, M.; Mahdavi, A.; Abbasi, E.; Iranshahy, M.; Sathyapalan, T.; Sahebkar, A. The effects of phytochemicals and herbal bio-active compounds on tumour necrosis factor-α in overweight and obese individuals: A clinical review. Inflammopharmacology, 2022, 30(1), 91-110.
[http://dx.doi.org/10.1007/s10787-021-00902-y] [PMID: 34997431]
[14]
Momtazi, A.A.; Banach, M.; Pirro, M.; Katsiki, N.; Sahebkar, A. Regulation of PCSK9 by nutraceuticals. Pharmacol. Res., 2017, 120, 157-169.
[http://dx.doi.org/10.1016/j.phrs.2017.03.023]
[15]
Cicero, A.F.G.; Colletti, A.; von Haehling, S.; Vinereanu, D.; Bielecka-Dabrowa, A.; Sahebkar, A.; Toth, P.P. Reiner, Ž; Wong, N.D.; Mikhailidis, D.P.; Ferri, C.; Banach, M. Nutraceutical support in heart failure: A position paper of the International Lipid Expert Panel (ILEP). Nutr. Res. Rev., 2020, 33(1), 155-179.
[http://dx.doi.org/10.1017/S0954422420000049] [PMID: 32172721]
[16]
Dadkhah Tehrani, S.; Shojaei, M.; Bagherniya, M.; Pirro, M.; Sahebkar, A. The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials. Phytother. Res., 2023, 37(4), 1640-1662.
[http://dx.doi.org/10.1002/ptr.7763] [PMID: 36756995]
[17]
Enayati, A.; Banach, M.; Jamialahmadi, T.; Sahebkar, A. Protective role of nutraceuticals against myocarditis. Biomed. Pharmacother., 2022, 146, 112242.
[http://dx.doi.org/10.1016/j.biopha.2021.112242] [PMID: 34953630]
[18]
Hosseini, A.; Penson, P.E.; Cicero, A.F.G.; Golledge, J.; Al-Rasadi, K.; Jamialahmadi, T.; Sahebkar, A. Potential benefits of phytochemicals for abdominal aortic aneurysm. Curr. Med. Chem., 2021, 28(41), 8595-8607.
[http://dx.doi.org/10.2174/0929867328666210614113116] [PMID: 34126879]
[19]
Kiani, Z.; Amini, S.; Askari, G.; Kesharwani, P.; Bagherniya, M.; Sahebkar, A. The effect of phytochemicals in prediabetic patients: A systematic review of randomized controlled trials. Phytother. Res., 2023, 37(8), 3239-3261.
[http://dx.doi.org/10.1002/ptr.7892] [PMID: 37246835]
[20]
Rizzo, M.; Colletti, A.; Penson, P.E.; Katsiki, N.; Mikhailidis, D.P.; Toth, P.P.; Gouni-Berthold, I.; Mancini, J.; Marais, D.; Moriarty, P.; Ruscica, M.; Sahebkar, A.; Vinereanu, D.; Cicero, A.F.G.; Banach, M.; Acosta, J.; Al-Khnifsawi, M.; Alnouri, F.; Amar, F.; Atanasov, A.G.; Bajraktari, G.; Banach, M.; Gouni-Berthold, I.; Bhaskar, S. Bielecka-Dąbrowa, A.; Bjelakovic, B.; Bruckert, E.; Bytyçi, I.; Cafferata, A.; Ceska, R.; Cicero, A.F.G.; Chlebus, K.; Collet, X.; Daccord, M.; Descamps, O.; Djuric, D.; Durst, R.; Ezhov, M.V.; Fras, Z.; Gaita, D.; Gouni-Berthold, I.; Hernandez, A.V.; Jones, S.R.; Jozwiak, J.; Kakauridze, N.; Kallel, A.; Katsiki, N.; Khera, A.; Kostner, K.; Kubilius, R.; Latkovskis, G.; John Mancini, G.B.; David Marais, A.; Martin, S.S.; Martinez, J.A.; Mazidi, M.; Mikhailidis, D.P.; Mirrakhimov, E.; Miserez, A.R.; Mitchenko, O.; Mitkovskaya, N.P.; Moriarty, P.M.; Mohammad Nabavi, S.; Nair, D.; Panagiotakos, D.B.; Paragh, G.; Pella, D.; Penson, P.E.; Petrulioniene, Z.; Pirro, M.; Postadzhiyan, A.; Puri, R.; Reda, A.; Reiner, Ž; Radenkovic, D.; Rakowski, M.; Riadh, J.; Richter, D.; Rizzo, M.; Ruscica, M.; Sahebkar, A.; Serban, M-C.; Shehab, A.M.A.; Shek, A.B.; Sirtori, C.R.; Stefanutti, C.; Tomasik, T.; Toth, P.P.; Viigimaa, M.; Valdivielso, P.; Vinereanu, D.; Vohnout, B.; von Haehling, S.; Vrablik, M.; Wong, N.D.; Yeh, HI.; Zhisheng, J.; Zirlik, A. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). Pharmacol. Res., 2023, 189, 106679.
[http://dx.doi.org/10.1016/j.phrs.2023.106679] [PMID: 36764041]
[21]
Soltani, S.; Boozari, M.; Cicero, A.F.G.; Jamialahmadi, T.; Sahebkar, A. Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis. Phytother. Res., 2021, 35(6), 2854-2878.
[http://dx.doi.org/10.1002/ptr.6991] [PMID: 33464676]
[22]
Mahboubi, M.; Mohammad Taghizadeh Kashani, L.; Mahboubi, M. Nigella sativa fixed oil as alternative treatment in management of pain in arthritis rheumatoid. Phytomedicine, 2018, 46, 69-77.
[http://dx.doi.org/10.1016/j.phymed.2018.04.018] [PMID: 30097124]
[23]
Tabrizi, R.; Moosazadeh, M.; Lankarani, K.B.; Akbari, M.; Heydari, S.T.; Kolahdooz, F.; Asemi, Z. The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. Probiotics Antimicrob. Proteins, 2018, 10(2), 329-342.
[http://dx.doi.org/10.1007/s12602-017-9299-1] [PMID: 28677046]
[24]
Hannan, M.A.; Rahman, M.A.; Sohag, A.A.M.; Uddin, M.J.; Dash, R.; Sikder, M.H.; Rahman, M.S.; Timalsina, B.; Munni, Y.A.; Sarker, P.P.; Alam, M.; Mohibbullah, M.; Haque, M.N.; Jahan, I.; Hossain, M.T.; Afrin, T.; Rahman, M.M.; Tahjib-Ul-Arif, M.; Mitra, S.; Oktaviani, D.F.; Khan, M.K.; Choi, H.J.; Moon, I.S.; Kim, B. Black cumin (Nigella sativa L.): A comprehensive review on phytochemistry, health benefits, molecular pharmacology, and safety. Nutrients, 2021, 13(6), 1784.
[http://dx.doi.org/10.3390/nu13061784] [PMID: 34073784]
[25]
Ahmad, A.; Husain, A.; Mujeeb, M.; Khan, S.A.; Najmi, A.K.; Siddique, N.A.; Damanhouri, Z.A.; Anwar, F. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac. J. Trop. Biomed., 2013, 3(5), 337-352.
[http://dx.doi.org/10.1016/S2221-1691(13)60075-1] [PMID: 23646296]
[26]
Namazi, N.; Mahdavi, R.; Alizadeh, M.; Farajnia, S. Oxidative stress responses to Nigella sativa oil concurrent with a low calorie diet in obese women: A randomized, double blind controlled clinical trial. Phytother. Res., 2015, 29(11), 1722-1728.
[http://dx.doi.org/10.1002/ptr.5417] [PMID: 26179113]
[27]
Ali, B.H.; Blunden, G. Pharmacological and toxicological properties of Nigella sativa. Phytother. Res., 2003, 17(4), 299-305.
[http://dx.doi.org/10.1002/ptr.1309] [PMID: 12722128]
[28]
Dajani, E.Z.; Shahwan, T.G.; Dajani, N.E. Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): A complementary drug with historical and clinical significance. J. Physiol. Pharmacol., 2016, 67(6), 801-817.
[PMID: 28195061]
[29]
Ahmad, M.F.; Ahmad, F.A.; Ashraf, S.A.; Saad, H.H.; Wahab, S.; Khan, M.I.; Ali, M.; Mohan, S.; Hakeem, K.R.; Athar, M.T. An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. J. Herb. Med., 2021, 25, 100404.
[http://dx.doi.org/10.1016/j.hermed.2020.100404] [PMID: 32983848]
[30]
Samarghandian, S.; Farkhondeh, T.; Samini, F. A review on possible therapeutic effect of Nigella sativa and thymoquinone in neurodegenerative diseases. CNS Neurol. Disord. Drug Targets, 2018, 17(6), 412-420.
[http://dx.doi.org/10.2174/1871527317666180702101455] [PMID: 29962349]
[31]
Khader, M.; Eckl, P.M. Thymoquinone: An emerging natural drug with a wide range of medical applications. Iran. J. Basic Med. Sci., 2014, 17(12), 950-957.
[PMID: 25859298]
[32]
Yimer, EM; Tuem, KB; Karim, A; Ur-Rehman, N Anwar, F Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses. Evid. Based Complement. Alternat. Med., 2019, 2019, 1-16.
[http://dx.doi.org/10.1155/2019/1528635] [PMID: 31214267]
[33]
Razavi, B.M.; Hosseinzadeh, H. A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome. J. Endocrinol. Invest., 2014, 37(11), 1031-1040.
[http://dx.doi.org/10.1007/s40618-014-0150-1] [PMID: 25125023]
[34]
Kavyani, Z.; Musazadeh, V.; Safaei, E.; Mohammadi Asmaroud, M.; Khashakichafi, F.; Ahrabi, S.S.; Dehghan, P. Antihypertensive effects of Nigella sativa supplementation: An updated systematic review and meta analysis of randomized controlled trials. Phytother. Res., 2023, 37(8), 3224-3238.
[http://dx.doi.org/10.1002/ptr.7891] [PMID: 37341696]
[35]
Naghsh, N.; Moridpour, A.H.; Kavyani, Z.; Musazadeh, V.; Jafarzadeh, J.; Safaei, E.; Clark, C.C.T.; Faghfouri, A.H. The effect of Nigella sativa (black seed) supplementation on body weight and body composition: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. J. Funct. Foods, 2023, 105, 105565.
[http://dx.doi.org/10.1016/j.jff.2023.105565]
[36]
Ciesielska-Figlon, K.; Wojciechowicz, K.; Wardowska, A.; Lisowska, K.A. The Immunomodulatory Effect of Nigella sativa. Antioxidants, 2023, 12(7), 1340.
[http://dx.doi.org/10.3390/antiox12071340] [PMID: 37507880]
[37]
Hadi, V; Pahlavani, N; Malekahmadi, M; Nattagh-Eshtivani, E; Navashenaq, JG; Hadi, S Nigella sativa in controlling Type 2 diabetes, cardiovascular, and rheumatoid arthritis diseases: molecular aspects. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 2021, 26
[38]
Mohtashami, A.; Mahaki, B.; Azadbakht, L.; Entezari, M.H. Effects of Bread with Nigella sativa on Lipid Profiles, Apolipoproteins and Inflammatory Factor in Metabolic Syndrome Patients. Clin. Nutr. Res., 2016, 5(2), 89-95.
[http://dx.doi.org/10.7762/cnr.2016.5.2.89] [PMID: 27152298]
[39]
Ibrahim, R.M.; Hamdan, N.S.; Ismail, M.; Saini, S.M.; Abd Rashid, S.N.; Abd Latiff, L.; Mahmud, R. Protective Effects of Nigella sativa on Metabolic Syndrome in Menopausal Women. Adv. Pharm. Bull., 2014, 4(1), 29-33.
[PMID: 24409406]
[40]
Fadishei, M.; Ghasemzadeh Rahbardar, M.; Imenshahidi, M.; Mohajeri, A.; Razavi, B.M.; Hosseinzadeh, H. Effects of Nigella sativa oil and thymoquinone against bisphenol A induced metabolic disorder in rats. Phytother. Res., 2021, 35(4), 2005-2024.
[http://dx.doi.org/10.1002/ptr.6944] [PMID: 33315269]
[41]
Haas, M.J.; Naem, E.; Almdallaleh, S.; Mooradian, A.D. The effect of black seed (Nigella sativa) extract on lipid metabolism in HepG2 cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 2022, 1867(8), 159155.
[http://dx.doi.org/10.1016/j.bbalip.2022.159155] [PMID: 35483558]
[42]
Heshmati, J.; Namazi, N. Effects of black seed (Nigella sativa) on metabolic parameters in diabetes mellitus: A systematic review. Complement. Ther. Med., 2015, 23(2), 275-282.
[http://dx.doi.org/10.1016/j.ctim.2015.01.013] [PMID: 25847566]
[43]
Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med., 2009, 151(4), 264-269. W64.
[http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135] [PMID: 19622511]
[44]
Cumpston, M; Li, T; Page, MJ; Chandler, J; Welch, VA; Higgins, JP Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions., 2019.
[http://dx.doi.org/10.1002/14651858.ED000142]
[45]
Borenstein, M.; Hedges, L.; Higgins, J.; Rothstein, H. Comprehensive meta-analysis version 3; Biostat: Englewood, NJ, 2013. software
[46]
Higgins, J.P.T.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414), 557-560.
[http://dx.doi.org/10.1136/bmj.327.7414.557] [PMID: 12958120]
[47]
DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials, 1986, 7(3), 177-188.
[http://dx.doi.org/10.1016/0197-2456(86)90046-2] [PMID: 3802833]
[48]
Egger, M.; Smith, G.D.; Schneider, M.; Minder, C. Bias in metaanalysis detected by a simple, graphical test. BMJ, 1997, 315(7109), 629-634.
[http://dx.doi.org/10.1136/bmj.315.7109.629] [PMID: 9310563]
[49]
Begg, C.B.; Berlin, J.A. Publication bias and dissemination of clinical research. J. Natl. Cancer Inst., 1989, 81(2), 107-115.
[http://dx.doi.org/10.1093/jnci/81.2.107] [PMID: 2642556]
[50]
Kooshki, A.; Tofighiyan, T.; Rastgoo, N.; Rakhshani, M.H.; Miri, M. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phytother. Res., 2020, 34(10), 2706-2711.
[http://dx.doi.org/10.1002/ptr.6707] [PMID: 32510754]
[51]
Mohammadshahi, M.; Rashidmayvan, M.; Ss, S.; Mh, H. The potential protective effect of Nigella sativa oil on patients with nonalcoholic fatty liver disease. Austin J Nutr Metab., 2018, 5(2), 1061.
[52]
Mostafa, T.M.; Hegazy, S.K.; Elnaidany, S.S.; Shehabeldin, W.A.; Sawan, E.S. Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformin. J. Diabetes Complications, 2021, 35(7), 107947.
[http://dx.doi.org/10.1016/j.jdiacomp.2021.107947] [PMID: 34006388]
[53]
Moustafa, H.A.M.; El Wakeel, L.M.; Halawa, M.R.; Sabri, N.A.; El-Bahy, A.Z.; Singab, A.N. Effect of Nigella sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients. Endocrine, 2019, 65(2), 286-294.
[http://dx.doi.org/10.1007/s12020-019-01963-4] [PMID: 31152309]
[54]
Rahmani, A; Niknafs, B; Naseri, M; Nouri, M; Tarighat-Esfanjani, A Effect of nigella sativa oil on oxidative stress, inflammatory, and glycemic control indices in diabetic hemodialysis patients: a randomized double-blind, controlled trial., 2022.
[http://dx.doi.org/10.1155/2022/2753294]
[55]
Rashidmayvan, M.; Mohammadshahi, M.; Seyedian, S.S.; Haghighizadeh, M.H. The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver. J. Diabetes Metab. Disord., 2019, 18(2), 453-459.
[http://dx.doi.org/10.1007/s40200-019-00439-6] [PMID: 31890671]
[56]
Amin, F.; Islam, N.; Anila, N.; Gilani, A.H. Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome – A double blind randomized controlled trial – TAK-MetS trial. Complement. Ther. Med., 2015, 23(2), 165-174.
[http://dx.doi.org/10.1016/j.ctim.2015.01.008] [PMID: 25847554]
[57]
Kaatabi, H.; Bamosa, A.O.; Badar, A.; Al-Elq, A.; Abou-Hozaifa, B.; Lebda, F.; Al-Khadra, A.; Al-Almaie, S. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PLoS One, 2015, 10(2), e0113486.
[http://dx.doi.org/10.1371/journal.pone.0113486] [PMID: 25706772]
[58]
Darand, M.; Darabi, Z.; Yari, Z.; Saadati, S.; Hedayati, M.; Khoncheh, A.; Hosseini-Ahangar, B.; Alavian, S.; Hekmatdoost, A. Nigella sativa and inflammatory biomarkers in patients with nonalcoholic fatty liver disease: Results from a randomized, doubleblind, placebo-controlled, clinical trial. Complement. Ther. Med., 2019, 44, 204-209.
[http://dx.doi.org/10.1016/j.ctim.2019.04.014] [PMID: 31126557]
[59]
Hadi, S; Mirmiran, P; Daryabeygikhotbehsara, R; Hadi, V. Effect of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress among people with type 2 diabetes mellitus: a randomized, double-blind, placebo controlled trial., 2018.
[60]
Shoaei-Hagh, P.; Kamelan Kafi, F.; Najafi, S.; Zamanzadeh, M.; Heidari Bakavoli, A.; Ramezani, J.; Soltanian, S.; Asili, J.; Hosseinzadeh, H.; Eslami, S.; Taherzadeh, Z. A randomized, Double‐blind, placebo controlled, clinical trial to evaluate the benefits of Nigella sativa seeds oil in reducing cardiovascular risks in hypertensive patients. Phytother. Res., 2021, 35(8), 4388-4400.
[http://dx.doi.org/10.1002/ptr.7140] [PMID: 33957004]
[61]
Tavakoli-Rouzbehani, O.M.; Abbasnezhad, M.; Kheirouri, S.; Alizadeh, M. Efficacy of nigella sativa oil on endothelial function and atherogenic indices in patients with coronary artery diseases: A randomized, double blind, placebo control clinical trial. Phytother. Res., 2022, 36(12), 4516-4526.
[http://dx.doi.org/10.1002/ptr.7568] [PMID: 35871718]
[62]
Abdollahi, N.; Nadjarzadeh, A.; Salehi-Abargouei, A.; Fallahzadeh, H.; Razmpoosh, E.; Lorzaedeh, E.; Safi, S. The effect of Nigella sativa on TAC and MDA in obese and overweight women: secondary analysis of a crossover, double blind, randomized clinical trial. J. Diabetes Metab. Disord., 2022, 21(1), 171-179.
[http://dx.doi.org/10.1007/s40200-021-00954-5] [PMID: 35673509]
[63]
Amin, B.; Hosseinzadeh, H. Black Cumin (Nigella sativa) and Its Active Constituent, Thymoquinone: An Overview on the Analgesic and Anti-inflammatory Effects. Planta Med., 2016, 82(1-2), 8-16.
[PMID: 26366755]
[64]
Bovolini, A.; Garcia, J.; Andrade, M.A.; Duarte, J.A. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int. J. Sports Med., 2021, 42(3), 199-214.
[http://dx.doi.org/10.1055/a-1263-0898] [PMID: 33075830]
[65]
van der Pal, K.C.; Koopman, A.D.M.; Lakerveld, J.; van der Heijden, A.A.; Elders, P.J.; Beulens, J.W.; Rutters, F. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: the New Hoorn study. Sleep Med., 2018, 52, 51-57.
[http://dx.doi.org/10.1016/j.sleep.2018.07.022] [PMID: 30278295]
[66]
Monserrat-Mesquida, M.; Quetglas-Llabrés, M. Capó, X.; Bouzas, C.; Mateos, D.; Pons, A.; Tur, J.A.; Sureda, A. Metabolic Syndrome Is Associated with Oxidative Stress and Proinflammatory State. Antioxidants, 2020, 9(3), 236.
[http://dx.doi.org/10.3390/antiox9030236] [PMID: 32178436]
[67]
Yubero-Serrano, EM; Delgado-Lista, J; Peña-Orihuela, P; Perez-Martinez, P; Fuentes, F; Marin, C 2013.
[68]
Fernandez-García, J.; Cardona, F.; Tinahones, F. Inflammation, oxidative stress and metabolic syndrome: dietary modulation. Curr. Vasc. Pharmacol., 2014, 11(6), 906-919.
[http://dx.doi.org/10.2174/15701611113116660175] [PMID: 24168441]
[69]
Sutherland, J.P.; McKinley, B.; Eckel, R.H. The metabolic syndrome and inflammation. Metab. Syndr. Relat. Disord., 2004, 2(2), 82-104.
[http://dx.doi.org/10.1089/met.2004.2.82] [PMID: 18370640]
[70]
Montazeri, R.S.; Fatahi, S.; Sohouli, M.H.; Abu-Zaid, A.; Santos, H.O. Găman, M.A.; Shidfar, F. The effect of Nigella sativa on biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomized controlled trials. J. Food Biochem., 2021, 45(4), e13625.
[http://dx.doi.org/10.1111/jfbc.13625] [PMID: 33559935]
[71]
Malekian, S.; Ghassab-Abdollahi, N.; Mirghafourvand, M.; Farshbaf-Khalili, A. The effect of Nigella sativa on oxidative stress and inflammatory biomarkers: a systematic review and meta-analysis. J. Complement. Integr. Med., 2021, 18(2), 235-259.
[http://dx.doi.org/10.1515/jcim-2019-0198] [PMID: 34187123]
[72]
Kavyani, Z.; Musazadeh, V.; Golpour-hamedani, S.; Moridpour, A.H.; Vajdi, M.; Askari, G. The effect of Nigella sativa (black seed) on biomarkers of inflammation and oxidative stress: an updated systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology, 2023, 31(3), 1149-1165.
[http://dx.doi.org/10.1007/s10787-023-01213-0] [PMID: 37036558]
[73]
Alkis, H.; Demir, E.; Taysi, M.R.; Sagir, S.; Taysi, S. Effects of Nigella sativa oil and thymoquinone on radiation-induced oxidative stress in kidney tissue of rats. Biomed. Pharmacother., 2021, 139, 111540.
[http://dx.doi.org/10.1016/j.biopha.2021.111540] [PMID: 33831837]
[74]
Liang, J.; Lian, L.; Wang, X.; Li, L. Thymoquinone, extract from Nigella sativa seeds, protects human skin keratinocytes against UVA-irradiated oxidative stress, inflammation and mitochondrial dysfunction. Mol. Immunol., 2021, 135, 21-27.
[http://dx.doi.org/10.1016/j.molimm.2021.03.015] [PMID: 33857815]
[75]
Ardiana, M.; Pikir, B.S.; Santoso, A.; Hermawan, H.O.; Al-Farabi, M.J. Effect of Nigella sativa Supplementation on Oxidative Stress and Antioxidant Parameters: A Meta-Analysis of Randomized Controlled Trials. ScientificWorldJournal, 2020, 2020, 1-7.
[http://dx.doi.org/10.1155/2020/2390706] [PMID: 32454800]
[76]
Amizadeh, S.; Rashtchizadeh, N.; Khabbazi, A.; Ghorbanihaghjo, A.; Ebrahimi, A.A.; Vatankhah, A.M.; Malek Mahdavi, A.; Taghizadeh, M. Effect of Nigella sativa oil extracts on inflammatory and oxidative stress markers in Behcet’s disease: A randomized, double-blind, placebo-controlled clinical trial. Avicenna J. Phytomed., 2020, 10(2), 181-189.
[PMID: 32257890]
[77]
Datau, E.A. Wardhana; Surachmanto, E.E.; Pandelaki, K.; Langi, J.A.; Fias, Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med. Indones., 2010, 42(3), 130-134.
[PMID: 20724766]
[78]
Li, Z.; Wang, Y.; Xu, Q.; Ma, J.; Li, X.; Yan, J.; Tian, Y.; Wen, Y.; Chen, T. Nigella sativa and health outcomes: An overview of systematic reviews and meta-analyses. Front. Nutr., 2023, 10, 1107750.
[http://dx.doi.org/10.3389/fnut.2023.1107750] [PMID: 37057067]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy